FNDC5 and chronic obstructive pulmonary disease: These findings suggest that insufficient irisin secretion in the skeletal muscles of patients with COPD may hinder its protective effect on mitochondrial function by reducing P-MAPK levels, leading to decreased skeletal muscle exercise capacity and 6MWD.